Stock 4502 TAKEDA PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-23 am EDT 		5-day change 1st Jan Change
4,134 JPY +0.78% Intraday chart for Takeda Pharmaceutical Company Limited -0.60% +1.97%
May. 16 Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment MT
May. 15 Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment
MT
Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification
MT
FDA extends review of Ascendis Pharma's hormone disorder therapy
RE
Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
MT
Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
MT
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Gainers
MT
AC Immune Enters Licensing Deal for Alzheimer's Disease Drug Candidate
MT
Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
MT
AC Immunity Shares Soar on Exclusive License Deal with Takeda
DJ
Takeda Pharmaceutical's Attributable Profit Falls 55% in Fiscal 2024
MT
Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup
DJ
Sector Update: Health Care Stocks Steady Pre-Bell Thursday
MT
Takeda Pharmaceutical's Fiscal Q1 Core Earnings Decline, Revenue Increases; Fiscal 2024 Outlook Issued
MT
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update
DJ
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
DJ
Japan's Takeda Pharma says full-year profit slumps 56%
RE
Takeda Pharmaceutical Company Limited Provides Earnings Guidance for the Full Year of 2024
CI
Takeda Pharmaceutical Company Limited Declares Dividend for the Year Ended March 31, 2024, Payable June 27, 2024; Provides Dividend Guidance for the Second Quarter-End and Year-End of Fiscal Year Ending March 31, 2025
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. News Takeda Pharmaceutical Company Limited
  5. Highlights